Effect of Clofibrate in Jaundiced Term newborns
Phase 3
- Conditions
- Jaundice in healthy, term newborn.
- Registration Number
- IRCT138706261162N4
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
healthy jaundiced, breastfed neonates, delivered between 38th and 41st week of gestational age after an uncomplicated pregnancy and serum bilirubin(TSB) between 17 and 29.9 mg/dl ,age less than 28 days
exclusion criteria: congenital anomaly, hemolytic disease (Rh or ABO incompatibility and a positive coombs' test), infection (congenital or acquired), dehydration, G6PD deficiency and conjugated bilirubin>2.0 mg/dl or exceeding 15% of total serum bilirubin,age more than 28 days
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubine. Timepoint: Before intervention-12,24 and 48 after intervention. Method of measurement: Measuring serum bilirobin(diazo method).
- Secondary Outcome Measures
Name Time Method Duration of need to phototrapy. Timepoint: daily. Method of measurement: Duration of phototherapy (days).